Clinical trials are slow. They're also narrow — a controlled cohort, a fixed questionnaire, a ruling on what counts as a "significant" symptom. That's fine for safety gatekeeping. It's less useful if you're actually on the drug and trying to figure out why you feel cold all the time.
Enter a new study out of the University of Pennsylvania, published in Nature Health this month. Researchers Neil Sehgal, Jena Shaw Tronieri, Lyle Ungar, and Sharath Chandra Guntuku used large language models to analyze over 400,000 Reddit posts from people on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), then mapped what those users reported against the official side effect profile.
The gap between the two is the story.
Why This Dataset Matters for Men Specifically
Reddit skews male. The study's authors acknowledge this openly — their sample is younger, more male, and more U.S.-based than the general GLP-1 population. For a site built around men's health, that's a feature, not a bug. This is the closest thing we have to a large-scale look at how guys are actually experiencing these drugs outside a clinical setting.
One finding that jumped out in coverage of the paper: men in the sample were more likely to report side effects than women. That runs counter to the usual pattern in adverse event reporting and suggests either better candid reporting in male-dominated Reddit communities, or real physiological differences in how men process these medications. Either way — worth tracking.
The Confirmed Stuff
The AI-analyzed Reddit data matched the known side effect profile almost exactly. This is actually important — it's the validation step that makes the novel findings credible.
| Symptom | % of users | On label? |
|---|---|---|
| Nausea | 36.9% | Yes |
| Fatigue | 16.7% | Inconsistent |
| Vomiting | 16.3% | Yes |
| Constipation | 15.3% | Yes |
| Diarrhea | 12.6% | Yes |
If the AI had pulled these numbers and they didn't match the known side effects, the whole methodology would be suspect. They did match. That's the signal that the other findings — the ones below — aren't noise.
The Signals Trials Missed
Three categories of symptoms showed up in Reddit conversations that either don't appear on current drug labeling or get dismissed as non-significant in trial reports.
Fatigue shows up in some trials, but because roughly 5% of placebo-group patients also report it, it gets filtered as non-significant. The Reddit data shows fatigue is actually one of the most commonly discussed experiences on GLP-1s. Real or placebo, if 1 in 6 guys on the drug are noticing it, that's worth dialing in.
Chills, persistent cold feelings, and hot flashes. Small percentages but consistent enough to flag. Potentially tied to metabolic shifts, loss of subcutaneous fat (which is your insulation), or direct thermoregulatory effects of the drug. Nobody was tracking this before.
Primarily menstrual irregularities on the female side. For men, the study doesn't break out specific hormonal data — but the broader story is that these drugs have hormonal downstream effects the trials didn't systematically track. If you're stacking GLP-1 with TRT or tracking any hormone markers, it's a reason to stay alert to shifts.
The Skeptic's Counter
Not everyone is convinced. Dr. Yuval Pinto, an obesity and family medicine physician at Johns Hopkins (not involved in the study), pushed back in an Everyday Health interview: Reddit is anonymous, users can't be verified, there's no placebo group, and rapid weight loss itself can cause many of these symptoms independent of the drug. Big fat-loss phases drop testosterone in men, alter thermoregulation, and strain recovery systems — regardless of whether you got there via GLP-1, caloric deficit, or a cutting cycle.
The study authors don't dispute this. They're explicit that the findings aren't causal. What they're saying is: these are signals worth investigating. Not conclusions.
That's a fair framing. A 400,000-post dataset doesn't replace a randomized controlled trial. It points to where the next trial should look.
What to Actually Do With This
If you're running GLP-1, here's the practical translation:
1. Track your stats like you'd track a cycle
Energy, sleep quality, morning wood, libido, temperature regulation, recovery between workouts. Weekly check-ins. This is standard operating procedure if you're on TRT or running any kind of performance protocol — extend it to your GLP-1 protocol. Patterns emerge over weeks, not days.
2. Don't let your provider dismiss weird symptoms
If fatigue, temperature issues, or hormonal shifts aren't on the "official" side effect list, some prescribers will brush them off. That's exactly what this study is pushing back on. Bring the symptoms up, ask for bloodwork if warranted, and if your provider isn't engaging — find one who will.
3. Watch your total hormonal picture
Rapid weight loss drops estrogen storage (body fat holds estrogen), which can shift your T:E ratio. Add GLP-1 effects on top of that, and guys on aggressive fat loss protocols should probably be pulling labs every 3-6 months. Total T, free T, estradiol, SHBG at minimum.
4. Adjust dose, don't just suffer
Many of the reported side effects — fatigue, GI issues, temperature changes — respond to dose adjustments. The titration ladder isn't mandatory; it's a tool. A provider who'll actually adjust protocol based on your symptoms is worth more than the cheapest prescription you can find.
Running a GLP-1 Stack?
Find a telehealth provider that offers real clinical support, dose adjustments, and ongoing monitoring — not just a shipping label.
Get Matched with a Provider →The Bigger Play: AI Pharmacovigilance Is Coming
Zoom out and this study is the opening shot in a new phase of drug safety monitoring. Clinical trials are rigorous but slow. FDA adverse event reports are thorough but delayed. Meanwhile, millions of people are comparing notes in real time on Reddit, Discord, X, and private forums.
The Penn team calls this "computational social listening" — using LLMs to turn unstructured patient conversation into structured safety data. Expect a lot more of this, and expect it to hit the compounded peptide scene hard next. That's a loosely regulated corner of the market where users are basically running their own trials with zero oversight.
For now: use what's actionable. The study confirmed that fatigue, temperature issues, and hormonal shifts are real patterns — not just your imagination. Track them. Report them. Adjust protocol.
Quick Reference: The Reddit Report
- Source: Sehgal et al., Nature Health, April 2026
- Method: LLM analysis of 410,198 Reddit posts (2019–2025)
- Confirmed: GI side effects (nausea, vomiting, constipation, diarrhea)
- Novel signals: Fatigue, temperature dysregulation, reproductive changes
- Caveat: Not causal — signals, not proof
- Takeaway for men: Track metrics, find a provider who listens, adjust dose based on symptoms
Sources
- Sehgal, N.K.R., Tronieri, J.S., Ungar, L., Guntuku, S.C. "Self-reported side effects of semaglutide and tirzepatide in online communities." Nature Health (2026). DOI: 10.1038/s44360-026-00108-y
- Penn Engineering. "Penn Researchers Use AI to Surface Unreported GLP-1 Side Effects in Reddit Posts." April 2026.
- Upham, B. "Reddit Users Are Reporting GLP-1 Side Effects Not Captured in Clinical Trials." Everyday Health, April 10, 2026.
Related Articles:
- GLP-1 Medications for Men: The Complete 2026 Guide
- Semaglutide vs Tirzepatide: Which Is Better for Men?
- GLP-1 and Testosterone: What the Research Actually Shows
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting, stopping, or changing any medication protocol.